Nevertheless, prolonged survival and remarkable response to ICIs as well as increased tumor mutational burden and neoantigen load were observed in melanoma patients with a profuse infiltration of CD4+ memory activated T cells and a lower fraction of CD4+ memory resting T cells (102). Here, CD4 is linked to melanoma.